CONDITION

Erythema Multiforme

Erythema multiforme is an inflammatory skin condition in which immune cells — specifically, CD8+ T lymphocytes — recognise certain skin cells (keratinocytes) as altered or foreign and trigger those cells to undergo programmed cell death, a process known as apoptosis. This often happens in response to an underlying trigger such as a medication, infection, or, in some cases, no identifiable cause. The result is damage at the junction between the outer and deeper layers of the skin, producing a characteristic pattern that pathologists call interface dermatitis. Owners most commonly notice reddened patches, ring-shaped or target-like marks, crusting, or ulceration, particularly at junctions where skin meets mucous membrane — around the lips, eyelids, nose, or genital openings — and sometimes on the paw pads, belly, armpits, or ear flaps. In more extensive cases, patches of skin or the surface of the paw pads may slough. The appearance can be striking, and the condition tends to develop relatively quickly. This page explores what these signs may reflect, what processes unfold beneath the skin, how the condition is investigated through biopsy and history, and what approaches exist to address both the skin changes and any identifiable underlying trigger. Erythema multiforme is not contagious and does not spread between animals.

Why this matters now

Erythema multiforme can appear at any age in dogs and cats, with no consistent life-stage pattern. No clear breed predisposition has been established. The condition often arises days to weeks after exposure to a trigger such as a medication, infection, or vaccination, though in many cases no clear precipitating event can be identified.

Lesions typically appear suddenly and may spread over hours to days, evolving from small red spots to larger rings or patches. Most cases resolve within two to four weeks if the underlying cause is removed or resolves on its own, though some animals experience waves of lesions that come and go over weeks to months. A smaller number develop more widespread involvement of the mouth, mucous membranes, or footpads, and the intensity of the reaction can vary considerably between individuals.

Signals & patterns

Early signals

Red spots or patches

Small, flat areas of redness may appear on the belly, groin, or inner thighs, sometimes noticed during grooming or when the animal lies down. These patches can be warm to the touch and may emerge quite suddenly.

Circular or spreading marks

Lesions often develop outward-spreading edges with a paler or darker centre, creating rings or annular shapes. This pattern tends to be more obvious on areas with sparse hair.

Mild crusting at lip or eyelid edges

The junction between skin and mucous membrane can become slightly red, tender, or develop fine crusts, particularly at the corners of the mouth or around the eyelids.

Subtle discomfort or licking

Some animals become quieter or lick at affected areas more than usual, though many show little obvious irritation early on.

Later signals

Ulcers in the mouth or on lips

Raw, painful areas may appear on the gums, tongue, or inner cheeks, sometimes making eating or drinking uncomfortable. Drooling or reluctance to chew can accompany these changes.

Swelling or crusting of footpads

The pads may become red, swollen, or develop thick crusts, and in more severe cases the outer layers can loosen or slough. Walking may become tender or hesitant.

Widespread skin involvement

Lesions can extend across the trunk, armpits, and genital area, sometimes merging into larger areas of redness, blistering, or crusting.

Click to read about the biological mechanisms

How this is usually investigated

The investigation of suspected erythema multiforme typically begins with a detailed history, focusing on any recent illnesses, medications, vaccinations, or exposures in the weeks before the skin changes appeared. The pattern and distribution of the lesions are noted during examination, with particular attention to the presence of annular or targetoid shapes and involvement of mucocutaneous junctions. Laboratory tests and tissue sampling help to confirm the diagnosis and exclude other conditions that can produce similar skin changes.

Physical examination

Purpose: A thorough examination maps the distribution of lesions, identifies involvement of mucocutaneous sites such as the mouth, eyelids, or genital area, and looks for signs of systemic illness that might point to an underlying trigger.
Considerations: The characteristic annular or targetoid lesions may not be present in all cases, and early or resolving lesions can appear less specific. The examination provides a snapshot but cannot determine the cause or confirm the diagnosis without tissue sampling.

Histopathology

Purpose: Microscopic examination of a skin biopsy can reveal the pattern of interface dermatitis, scattered apoptotic keratinocytes, and immune cell infiltration that are typical of erythema multiforme, helping to distinguish it from other immune-mediated or infectious skin conditions.
Considerations: The findings on histopathology can overlap with other interface dermatitides, and the pathologist may report features compatible with erythema multiforme rather than a definitive diagnosis. The timing of the biopsy matters, as older or healing lesions may show less specific changes.

Complete blood count

Purpose: A blood count may help identify signs of infection, inflammation, or immune system changes that could be contributing to the condition or indicate a concurrent illness.
Considerations: Many animals with erythema multiforme have normal blood counts, and abnormalities, when present, are often non-specific and do not point to a single cause.

Chemistry panel

Purpose: Biochemistry testing can reveal organ dysfunction or metabolic disturbances that might be contributing to the immune-mediated response or represent complications of the condition.
Considerations: Abnormalities are uncommon in uncomplicated erythema multiforme, but the panel may be useful in animals that are systemically unwell or in whom drug toxicity is suspected.

Bacterial culture and sensitivity

Purpose: Culture of skin lesions or swabs from mucosal ulcers can identify bacterial infection that may have triggered the condition or complicated existing lesions, and guide the choice of antimicrobial therapy if needed.
Considerations: Bacterial growth from skin lesions does not always indicate a primary infection, as secondary colonisation is common in damaged skin. Culture results must be interpreted alongside the clinical picture and histopathology findings.

Options & trade-offs

Management of erythema multiforme is usually tailored to the individual animal, taking into account the extent of the lesions, the presence or absence of an identifiable trigger, and the owner's ability to deliver treatments over the weeks to months that may be required for resolution. Some animals improve with removal of a suspected trigger alone, whilst others require immune-modulating drugs to settle the inflammatory response. The approaches described below are often used in combination, and what works well for one animal may be less practical or effective for another.

Identification and removal of triggers

When a medication, food, or environmental exposure is suspected, withdrawing the substance and monitoring for improvement can be both diagnostic and therapeutic. Common triggers include antibiotics, anticonvulsants, and non-steroidal anti-inflammatory drugs, though infections such as upper respiratory viruses or bacterial skin infections may also play a role. In cases where a recent vaccination or new food coincided with the onset of lesions, those items are typically avoided going forward.

Trade-offs: In many cases no clear trigger is identified even after careful review, and lesions may persist or recur despite withdrawal of suspected substances. The time to improvement after trigger removal varies, and some animals require additional treatment to control the immune response whilst the skin heals.

Immunosuppressive or immunomodulatory medication

Drugs such as prednisolone, ciclosporin, or azathioprine (in dogs only) may be used to dampen the immune-mediated attack on keratinocytes and allow the skin to repair. The choice of drug, dose, and duration depend on the severity of the lesions, the response to initial treatment, and the need to balance efficacy with the risk of side effects. Treatment is often started at higher doses and then gradually reduced as the lesions resolve, with the aim of finding the lowest dose that maintains control or achieving complete withdrawal if the trigger has been removed.

Trade-offs: Immunosuppressive drugs carry the risk of increased susceptibility to infection, changes in appetite and thirst, gastrointestinal upset, and, with longer-term use, effects on the liver, bone marrow, or other organs that require monitoring. Some animals show incomplete or slow responses, and relapse can occur when medication is reduced or stopped.

Supportive skin care

Gentle cleaning of ulcerated or crusted areas with dilute antiseptic solutions, application of emollient or barrier creams, and protection of affected mucosal surfaces can reduce discomfort and the risk of secondary bacterial infection whilst the immune response settles. In animals with oral lesions, softer foods or those that are easier to swallow may be more comfortable, and pain relief may be considered if the mouth or other areas are particularly tender.

Trade-offs: Supportive care alone does not address the underlying immune process and is unlikely to resolve moderate to severe cases without additional treatment. The practicality of topical treatments depends on the animal's tolerance and the owner's ability to apply them safely and consistently.

Antimicrobial therapy

If bacterial culture or clinical signs suggest secondary infection of the skin lesions, a course of antibiotics may be used to reduce bacterial load and allow the skin to heal more effectively. The choice of antimicrobial is guided by culture and sensitivity results where available, or by empirical selection based on the likely organisms involved.

Trade-offs: Antimicrobials treat secondary infection but do not alter the immune-mediated process driving the lesions, and overuse or inappropriate selection can contribute to resistance. In some cases the antimicrobial itself may have been the trigger for the erythema multiforme, so careful consideration is needed when deciding whether to start or continue these drugs.

Monitoring and adjustment over time

Regular follow-up allows the clinician to assess the response to treatment, adjust drug doses, watch for side effects, and identify recurrence early. Monitoring may include repeat physical examinations, blood tests to check organ function and blood cell counts, and discussions with the owner about the animal's comfort and quality of life. The goal is to achieve resolution or stable control with the lowest burden of treatment.

Trade-offs: Frequent visits and repeated blood tests add to the cost and time commitment of managing the condition, and not all animals tolerate venepuncture or handling well. The unpredictable nature of the condition means that even with careful monitoring, some animals experience relapses or fail to achieve complete resolution.

Common misconceptions

Misconception:

"Erythema multiforme is contagious to other animals or people in the household."

Reality:

Erythema multiforme is an immune-mediated condition, not an infectious disease, and cannot be spread from one individual to another. Whilst an infection such as a virus or bacterium may have triggered the immune response in the affected animal, the skin lesions themselves represent the body's reaction to that trigger rather than active shedding of a pathogen.

Misconception:

"The lesions will clear up on their own without any treatment."

Reality:

Whilst some mild cases may resolve spontaneously once the trigger is removed or the immune response settles, many animals require medical intervention to control the inflammation and prevent progression to more extensive skin damage or ulceration. The course is variable, and waiting to see if lesions resolve without treatment carries the risk of worsening in the interim.

Misconception:

"Once the lesions have healed, the condition will never come back."

Reality:

Recurrence is possible, particularly if the animal is re-exposed to the same trigger or if no trigger was identified in the first episode. Some animals experience a single episode with complete resolution, whilst others have intermittent flares over months to years, requiring ongoing vigilance and, in some cases, long-term low-dose medication to maintain control.

Animals with erythema multiforme often benefit from a broader understanding of immune-mediated skin conditions and the factors that can influence immune system reactivity. The Immune & Inflammatory Health pillar offers context on how the body's defences can sometimes turn against its own tissues, and what shapes an individual's susceptibility to these reactions. For animals in whom a clear trigger was never identified, or for those experiencing recurrent episodes, a conversation about environmental and dietary exposures, vaccination schedules, and the timing of any new medications can be a useful part of ongoing care.